Medicines Co (MDCO) Return on Equity ROE from the third quarter 2019 to third quarter 2018 and annually, average high and low, overall ranking from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Medicines Co  (NASDAQ: MDCO)

Medicines Co's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Medicines Co in the third quarter 2019?
Due to the lack of equity, it was not possible to calculate Medicines Co's return on equity (ROE) in its third quarter 2019

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Equity Change - 79.61 % - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -236 -218 -212 -123 -259
Return On Equity (TTM) - - - -1229.81 % -1187.33 %
MDCO's Total Ranking # # # # #
Equity (TTM) in Millions -60 38 -75 -22 -27
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to MDCO Management Effectiveness >> MDCO's 5 Years Annual ROE >> Compare MDCO ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





MDCO Annual Return On Equity (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Equity in Millions -22 25 652 732 920
Y / Y Equity Change - -96.18 % -10.9 % -20.47 % 3.13 %
Net Income in Millions -123 -708 -119 -353 -32
Y / Y Net Income Change - - - - -
Return On Equity - -2843.27 % -18.28 % -48.2 % -3.5 %

Back to MDCO Management Effectiveness >> MDCO's 5 Years Annual ROE >> Compare MDCO ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MDCO's' Return on Equity at Yahoo Finance
MDCO's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MDCO's Competitors
Subscribers only: Roe for Medicines Co's Suppliers
Subscribers only: Return On Equity for MDCO's Customers




Companies with similar Return On Equity at Sep 30 2019, within Healthcare Sector ROE
Zomedica Corp   699.60 %
Fuse Medical Inc   431.91 %
Idexx Laboratories Inc  405.77 %
Tuhura Biosciences Inc   357.89 %
Tenax Therapeutics Inc   241.44 %
Jounce Therapeutics inc   196.08 %
Innoviva Inc   180.94 %
Semler Scientific inc   177.82 %
Eli Lilly And Company  160.61 %

Date modified: 2026-09-08T15:09:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.